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interest in reduced glomerular filtration rate (GFR) as an 
independent non-traditional risk factor for CVD and 
CVD mortality has come to the fore [4,5]. Studies suggest 
that reduced GFR may be an independent risk factor 
for poor outcomes in patients with myocardial infarction 
and stroke [6-8]. Yohalom et al. [8], in a prospective 
study involving 821 Israeli adults with acute stroke, found 
that reduced GFR was a strong independent predictor of 
mortality and poor outcomes. Mortality was associated 
AbstRAct
Background: Chronic kidney disease (CKD) and stroke constitute worldwide public health problems with rising 
incidence, prevalence and poor outcomes. While the link between renal dysfunction and myocardial infarction is  
well established, the link with stroke has been less well investigated. In this study, the prevalence and prognostic 
implication of renal dysfunction in patients admitted with acute stroke was assessed.
Methods: This was a prospective observational study of 130 patients with first-ever stroke admitted within 7 days 
of stroke onset and followed up for 30 days. The study outcome measure was 30-day mortality. Stroke subtype was 
verified by a computerized tomography (CT) scan of the brain. Estimated g lomerular fi ltration rate (eGFR) was 
calculated from serum creatinine using the 4-variable Modification o f D iet i n Renal D isease (MDRD) equation.  
Renal dysfunction was defined as eGFR < 60 mL/min/1.73 m2 and s ignificant proteinuria was defined as urinary 
protein excretion ≥ 0.5 g in 24 hours. The Cox proportional hazards regression model was used to determine the 
relationship between GFR, proteinuria and 30-day mortality.
Results: The majority of the patients studied (56%) were male and their mean age was 61.3 ± 13.9 years. Ischaemic 
stroke was the most common stroke subtype, accounting for 74% of all cases.  Overall, 38% of patients had reduced 
eGFR < 60 mL/min/1.72 m2 while 35% had significant proteinuria. eGFR < 60 mL/min/1.73 m2 (hazard ratio, HR 
3.59, 95% CI 1.03–13.26, p < 0.001) and proteinuria (HR 1.86, CI 1.00–8.14, p = 0.035) were independent pre-
dictors of mortality. Other independent predictors were age > 70 years, haemorrhagic stroke subtype, CNS score 
< 6.5 and random blood glucose > 7.8 mmol/L.
Conclusions: Renal dysfunction is common among adult Nigerian patients with acute stroke. Both reduced 
eGFR and proteinuria were independent predictors of 30-day mortality in these patients. 
Keywords: renal dysfunction; chronic kidney disease; proteinuria; stroke; mortality.
INtRODUctION
Cardiovascular disease (CVD) is common among patients 
with chronic kidney disease (CKD) and accounts for 
about 50% of the deaths in this group [1]. It has been 
suggested that patients with CKD are more likely to die 
from cardiovascular events than they are to progress to 
end-stage renal disease (ESRD) [2]. This predisposition 
to adverse cardiovascular outcomes is attributable to the 
high prevalence of both traditional and non-traditional 
CVD risk factors seen in patients with CKD [3]. Recently, 
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with the severity of renal impairment, with individuals in 
the lowest GFR category (15–44 mL/min/1.73 m2) exhib-
iting a 3-fold increased relative risk of mortality at one 
year compared with individuals with GFR > 60 mL/min/ 
1.73 m2 [8].  Hao et al. also found that reduced eGFR on 
admission was a strong predictor of poor outcomes in 
patients with acute haemorrhagic stroke [9]. 
Stroke is relatively common in Nigeria and previous 
studies reported a high 30-day case fatality rate ranging 
from 41–60% [10]. There are, however, limited data 
available on the association between renal dysfunction 
and stroke outcomes among Nigerian patients with acute 
stroke. To provide further data on this association, this 
study evaluated the relationship between markers of renal 
dysfunction (reduced GFR and proteinuria) and 30-day 
mortality in patients admitted with acute stroke at a 
teaching hospital in Lagos, Nigeria.
MEtHODs
This was a prospective, observational study of 130 con-
secutive patients with acute stroke admitted into the 
medical wards of Lagos University Teaching Hospital 
(LUTH), an 800-bed hospital in Lagos, South-West 
Nigeria. The hospital provides tertiary care to over 20 
million inhabitants of Lagos and its environs. Patients were 
recruited into the study if they were at least 18 years of 
age, had experienced a first-ever stroke, presented within 
7 days of onset of stroke symptoms and consented to 
participate in the study. Patients who were experiencing a 
repeat stroke and those who were pregnant were excluded 
from the study. 
Socio-demographic and clinical information was obtained 
from study participants using an interviewer-administered 
questionnaire. Information sought included patients’ age, 
gender, risk factors for stroke including a history of hyper-
tension, diabetes and smoking, and current medications. 
Each patient underwent a physical examination that was 
focused on blood pressure measurement, level of con-
sciousness and degree of neurological deficit. The diagnosis 
of stroke was made in accordance with the World Health 
Organization (WHO) criteria [10,12], while stroke subtype 
was confirmed by computerised tomography (CT) scan of 
the brain. Stroke severity was assessed using the Canadian 
Neurological Scale (CNS) [12-14]. A blood sample was 
obtained for complete blood count, serum urea, creatinine, 
total cholesterol and glucose. A 24-hour sample of urine 
was collected for determination of urinary protein excre-
tion. GFR was estimated from standardized serum creatinine 
using the 4-variable Modification of Diet in Renal Disease 
(MDRD) equation. Serum creatinine was measured using 
the Jaffe alkaline picrate method (Hoffmann-La Roche, 
USA) traceable to isotope dilution mass spectrometry 
values [15]. 
All patients were followed up for 30 days post-stroke. The 
outcome of interest was death within 30 days. The follow-
ing operational definitions were adopted: reduced GFR 
was defined as eGFR < 60 mL/min/1.73 m2 whereas signifi-
cant proteinuria was defined as urine protein excretion of 
≥ 0.5 g/day. Patients were considered hypertensive if they 
were previously diagnosed with hypertension or were 
using antihypertensive medications or had systolic blood 
pressure > 140 mmHg or diastolic BP > 90 mmHg. Diabetes 
was diagnosed in the presence of hyperglycaemia or the 
use of oral hypoglycaemic agents or insulin. 
Data were analysed using the Statistical Package for Social 
Sciences (SPSS®) version 21. Categorical variables are pre-
sented as percentages while continuous variables are 
presented as mean ± standard deviation (SD). Baseline 
characteristics were compared between participants with 
eGFR > 60 mL/min/1.73 m2 and those with eGFR < 60 mL/
min/1.73 m2, those with and those without significant 
proteinuria, those who were alive at 30 days post-stroke 
and those who had died during the period. Differences in 
categorical variables were compared using chi-squared 
and Fischer’s exact tests, and Student’s t-test was used 
to compare numerical variables. The Mann–Whitney test 
was used for continuous variables not normally distri- 
buted. The Cox proportional hazard regression model was 
used to examine the relationship between eGFR, pro-
teinuria and 30-day mortality. The level of statistical signi-
ficance was set at a p value < 0.05.
Ethical approval was granted by the Health Research Ethics 
Committee (HREC) of Lagos University Teaching Hospital 
(reference no: ADM/DCST/HREC/168). 
REsULts
Of the 130 participants recruited into the study, 73 (56.2%) 
were males. The mean age was 61.3 ± 13.9 years (range 
27–80 years). Figure 1 shows the age distribution of 
the study population. The predominant age group was 
61–70 years. Table 1 shows the baseline characteristics of 
the study population stratified by gender. Most patients 
(73.8%) had ischaemic stroke and the mean duration from 
onset of stroke symptoms to hospital presentation was 
2.0 ± 1.4 days. Male participants reported a higher fre-
quency of smoking and a higher mean serum creatinine 
concentration; all other parameters were similar in both 
genders.
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clinical presentations in patients with  
renal dysfunction
Table 2 shows a comparison of the clinical and laboratory 
parameters of patients who had reduced eGFR with 
those with eGFR > 60 mL/min/1.73 m2. The proportion of 
patients with low eGFR was 37.7% and those with signifi-
cant proteinuria was 35.4%. Patients with reduced eGFR 
were older, more likely to be female, more likely to be 
smokers, had worse CNS scores, higher serum urea and 
lower haematocrit. They also had a higher 30-day mortality 
compared with the reference group (73.6% vs. 10.8%, 
p < 0.001). 
Thirty-eight patients died within 30 days of a stroke 
(mortality rate 29.2%). Table 3 compares the clinical and 
laboratory parameters of patients who died with those 
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table 1. Comparison of characteristics of study participants by gender.
Variable
All patients 
n = 130 
(Mean ± SD)
Females
n = 57
(Mean ± SD)
Males
 n = 73 
(Mean ± SD)
P-value
Age (years) 61.3 ±13.9 62.5 ± 13.8 60.4 ± 14.1 0.397
Duration of symptoms (days) 2.0 ± 1.4 2.1 ± 1.6 1.9 ± 1.3 0.438
History of hypertension (%) 101 (77.7) 49 (85.9) 52 (71.2) 0.057
History of diabetes mellitus (%) 16 (12.3) 6 (10.5) 8 (13.7) 1.000
Smoking history (%) 10 (7.7) 0 (0) 10 (13.7) 0.010
Systolic BP (mmHg) 177.6 ± 32.8 178.4 ± 27.3 177.0 ± 36.7 0.810
Diastolic BP (mmHg) 102.8 ± 20.9 99.1 ± 20.6 105.9 ± 20.8 0.066
Mean arterial pressure (mmHg) 127.8 ± 22.2 125.5 ± 20.3 129.6 ± 24.8 0.262
Stroke subtype
Ischaemic (%) 96 (73.8) 45 (78.9) 51 (69.9) 0.315
Haemorrhagic (%) 34 (26.2) 12 (21.1) 22 (30.1)
CNS scores category (%)
<6.5 56 (43.1) 28 (49.1) 28 (38.4) 0.284
≥6.5 74 (56.9) 29 (50.9) 45 (61.6)
Haematocrit % 34.5 ± 5.8 34.4 ± 5.8 34. 6 ± 5.8 0.961
Serum urea (mmol/L) 6.6 ± 2.4 6.3 ± 2.4 6.8 ± 2.3 0.230
Creatinine (μmol/L) 114.9 ± 44.2 97.2 ± 44.2 123.8 ± 44.2 0.001
eGFR (mL/min/1.73 m2) 70.5 ± 25.3 69.2 ± 23.6 71.6 ± 26.6 0.593
Urine protein (mg/24 hr) 436.8 ± 276.1 438.5 ± 286.1 440.2 ± 264.8 0.972
Random blood glucose (mmol/L) 7.3 ± 2.9 7.8 ± 3.3 6.9 ± 2.5 0.079
Total cholesterol (mmol/L) 5.40 ± 0.66 5.45 ± 0.65 5.36 ± 0.66 0.439
Figure 1.  Age distribution of the study population.
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who survived to 30 days. Patients who died were older, 
more likely to have had haemorrhagic stroke, poor CNS 
scores, higher RBG, higher total cholesterol, lower eGFR, 
higher frequency of severe hypertension and proteinuria.
Independent predictors of short-term mortality were 
advanced age, low eGFR, signif icant proteinuria and 
haemorrhagic stroke (Table 4).
DIscUssION
There is growing evidence of the relationship between 
renal dysfunction and cardiovascular morbidity and mor-
tality [2-4]. In this study, 37% of subjects with acute 
stroke had renal dysfunction defined as eGFR < 60 mL/
min/1.73 m2. Reports in the literature have shown that 
the prevalence of CKD in stroke patients ranges between 
28–47% [11,16,17]. Our finding is comparable to the 
study by Yahalom et al., who reported a prevalence of 
36% among patients with acute stroke in Israel [16] but 
differs from the study by Xu et al. in China, who reported 
a higher prevalence of 47% [17].  This higher prevalence 
may be explained by the fact that Xu et al. included sub-
jects in all five CKD stages and not just those with GFR 
< 60 mL/min/1.73 m2 [17].
About one-third of our participants had significant pro-
teinuria. This differs from the study by Xu et al., who 
reported a prevalence of microalbuminuria and proteinuria 
of 11.2% and 24.8%, respectively [17]. In that study, micro-
albuminuria was determined by measuring the albumin- 
to-creatinine ratio (ACR) in spot urine samples whereas 
proteinuria was determined semi-quantitatively by routine 
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table 2. Comparison of characteristics of study participants stratified by eGFR.
Variable
All patients 
n = 130 
(Mean ± SD)
eGFR ≥ 60 mL/ 
min/1.73 m2
n = 81
(Mean ± SD)
eGFR ≥ 60 mL/ 
min/1.73 m2
 n = 49 
(Mean ± SD)
P-value
Females (%) 57 (43.8) 20 (24.7) 37 (75.5)  0.001
Hypertension (%) 101 (77.7) 60 (74.1) 41 (83.7) 0.277
Diabetes mellitus (%) 16 (12.3) 8 (9.9) 8 (16.3) 0.286
Current smokers (%) 10 (7.7) 3 (3.7) 7 (14.3) 0.041
Stroke subtype
Ischaemic (%) 96 (73.8) 64 (79.0) 32 (65.3) 0.101
Haemorrhagic (%) 34 (26.2) 17 (21) 17 (34.7)
CNS scores category
< 6.5 56 (43.1) 29 (35.8) 27 (55.1)  0.044
≥ 6.5 74 (56.9) 52 (64.2) 22 (44.9)
Duration of symptoms (days) 2 ± 1.44  2.1 ± 1.61 1.9 ± 1.32 0.465
Systolic BP (mmHg) 177.6 ± 32.8 174.6 ± 30.9 182.6 ± 35.5 0.178
Diastolic BP (mmHg) 102.8 ± 20.9 100.6 ± 18.5 106.7 ± 24.2   0.545
Mean arterial pressure (mmHg) 127.8 ± 22.2 125.3 ± 20.4 132.0 ± 26.3 0.107
Serum urea (mmol/L) 6.6 ± 2.37 5.8 ± 1.65 7.9 ± 2.75 0.001
Urine protein (mg/24 hr) 436.8 ± 276.1 414.6 ± 276.7 480.5 ± 265.1 0.184
Random blood glucose (mmol/L) 7.3 ± 2.9   7.4 ± 3.0   7.3 ± 2.7 0.849
Total cholesterol (mmol/L) 5.40 ± 0.66 5.34 ± 0.67 5.49 ± 0.63 0.208       
Haematocrit (%) 34.5 ± 5.8 35.8 ± 5.6 32.4 ± 5.4 0.001
30-day mortality rate (%) 38 (29)                 10 (10.8) 28 (73.6) 0.001         
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urinalysis. Unlike the study by Xu et al., which used the 
ACR on spot urine samples, we collected 24-hour urine 
samples to determine total protein excretion. 
We observed that reduced GFR and proteinuria were 
associated with higher 30-day mortality. Several studies 
have found an association between renal dysfunction and 
poor cardiovascular outcomes [9,11,16,17,18]. Tsahalis 
et al. reported that renal dysfunction is an independent 
prognostic factor for mortality and new cardiovascular 
morbidity in acute stroke [11].  Similarly, Hao et al., in 
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table 3. Comparison of clinical characteristics of stroke patients who died within 30 days with those who survived.
Variable
All patients 
n = 130 
(Mean ± SD)
Survived
n = 92
(Mean ± SD)
Died
 n = 38 
(Mean ± SD)
P-value
Age (years) 61.3 ±13.9 57.3 ± 12.6 71.1 ± 12.3 0.001
Females (%) 57 (43.8) 39 (42.4) 18 (47.4) 0.524
Hypertension (%) 101 (77.7) 69 (75) 32 (84.2) 0.350
Stroke subtype
Haemorrhagic (%) 34 (26.2) 17 (18.5) 17 (44.7) 0.004
CNS scores category
< 6.5 56 (43.1) 27 (29.3) 29 (76.3) 0.000
Duration of symptoms (days) 2.0 ± 1.4 2.1 ± 1.61 1.9 ± 1.3 0.500
Mean arterial pressure (mmHg) 127.8 ± 22.2 127.5 ± 20.8 128.6 ± 27.7 0.805
Serum urea (mmol/L) 6.6 ± 2.4 6.15 ± 1.97 7.67 ± 2.86 0.001
Creatinine (μmol/L) 114.9 ± 44.2 116.7 ± 40.7 151.2 ± 49.5 0.000
Urine protein (mg/24 hr) 436.8 ± 276.1 416.5 ± 264.9 494.9 ± 288.4 0.137
Random blood glucose (mmol/L) 7.3 ± 2.9 6.8 ± 1.9 8.7 ± 4.2       0.001
Total cholesterol (mmol/L) 5.40 ± 0.66 5.27 ± 0.52 5.70 ± 0.84 0.000
Haematocrit (%) 34.5 ± 5.8 34.9 ± 5.5 33.6 ± 6.3     0.243
eGFR < 60 mL/min/1.73 m2 (%) 49 (37.7) 21 (22.8) 28 (73.7) 0.000
Proteinuria > 500 mg/24 hours (%) 46 (35.4) 27 (29.3)        19 (50) 0.029
Proportion with severely elevated BP (%) 83 (63.8)                 64 (69.6)                19 (50)        0.045                
table 4. Cox proportional hazards model for predictors of 30-days mortality.
Variable HR CI 95% P-value
Age > 70 years                 4.25 5.12–57.07 0.001
GCS < 8                       0.45 0.03–6.18 0.828
CNS < 6.5 3.61 0.86–15.15 0.048
Haemorrhagic stroke 2.00 2.09–19.65 0.009
GFR < 60 mL/min/1.73 m2 3.59 1.03–13.26 0.001
Urine protein > 0.5 g/24 hr 1.86 1.00–8.14 0.035
RBG > 140 mg/dL (> 7.8 mmol/L) 4.54 1.27–16.29 0.020
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China, found that reduced eGFR on admission was a 
strong predictor of poor outcomes for acute stroke [9]. 
Yahalom et al. assessed the association between baseline 
eGFR and 1-year outcomes in 821 consecutive patients 
with acute stroke and found that CKD was present in 
36% of their patients. eGFR < 45 mL/min/1.73 m2 was a 
strong independent predictor of mortality and poor 
outcomes, whereas milder reductions in GFR (> 45 mL/
min/1.73 m2) was not associated with mortality [16]. The 
mechanism by which renal dysfunction is associated with 
poor outcomes would include a higher prevalence of 
both traditional and non-traditional cardiovascular risk 
factors [17,19,20]. In our study, the prevalence of hyper-
tension was relatively high. Hypertension is a strong risk 
factor for stroke, especially among Blacks. Black patients 
with hypertension have a 1.3 times greater rate of non- 
fatal stroke and 1.8 times greater rate of fatal stroke [7,21]. 
Similarly, the majority of the subjects had anaemia, one of 
the non-traditional cardiovascular risk factors. The pre-
valence of anaemia increases as GFR declines [16,19,20].
Our study also found that proteinuria was associated with 
an increased risk of death in acute stroke, as previously 
reported in other studies [11,18]. Significant proteinuria is 
indicative of more severe kidney damage and this may 
explain the poor outcomes seen with proteinuric CKD. 
This finding is comparable to the study by Ovbiagele et al. 
in the United States, who reported that among ischaemic 
stroke patients without known CKD, proteinuria on admis-
sion was independently linked with lower odds of going 
home directly from the hospital, and a poorer functional 
status upon discharge [22]. This was corroborated in the 
study by Xu et al. [17]. Similarly, preliminary results of 
the Kidney Early Evaluation Program (KEEP) found that 
eGFR < 60 mL/min/1.73 m2 or urine albumin:creatinine 
ratio > 30 was associated with poorer outcomes in myo-
cardial infarction or stroke [23]. In that study, a poor CNS 
score, high level of RBG, haemorrhagic stroke subtype 
and advanced age were also associated with increased 
risk of death. Chambers et al. also reported that advanced 
age was a predictor of short-term mortality in acute 
stroke [24]. Furthermore, Colombo et al. showed that 
haemorrhagic stroke and advanced age were the predic-
tors of mortality in 503 stroke patients [25]. The Besançon 
stroke registry in France indicated that among 2500 
consecutive patients with stroke, independent predictors 
of poor outcome were age > 70 years, hyperglycaemia 
and female gender [26].  Censori et al., in Italy, showed 
that a Canadian Neurological Scale score < 6.5 at entry 
was associated with signif icant handicap or death at 30 
days [27].  A Nigerian study reported furthermore that 
predictors of poor outcomes in acute stroke were hyper-
glycaemia, haemorrhagic stroke, DBP, aspiration pneumonia, 
raised intracranial pressure and NIHSS score > 20 [28]. 
Our study has some limitations. GFR was assessed using 
prediction equations rather than by gold standard methods 
of measurement [29]. Second, it was conducted in a single 
centre. Larger, multicentre studies are required to confirm 
our findings. Lastly, since we had no renal function data 
prior to the stroke suffered by our patients, the low GFR 
may have developed subsequent to dehydration following 
the stroke. This, however, is unlikely in our centre as our 
treatment protocol emphasizes rehydrating all patients 
who present with acute stroke.
cONcLUsIONs
Reduced GFR and proteinuria, which are indices of renal 
dysfunction, are strong predictors of 30-day mortality after 
acute stroke. We recommend that all patients with acute 
stroke be screened routinely for evidence of renal 
dysfunction. 
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